Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- CheckyesterdayChange DetectedThe page now presents the study header and provenance details along with a version-history section, including the study title, sponsor, investigator, and dates for study record versions.SummaryDifference10%

- Check8 days agoChange DetectedThe page version removes several history and export options, reducing the UI elements shown for version history and related actions.SummaryDifference7%

- Check15 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 in the page footer, indicating a new release version. No substantive content changes are reflected in this update.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history page’s footer/site revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site version change rather than a change to the clinical trial record.SummaryDifference0.1%

- Check44 days agoChange DetectedA new record revision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the Record History page, indicating a new version of the study record.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.